Esophageal carcinoma (squamous + adeno) · line 1 · None
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.
| Line of therapy | 1 |
|---|---|
| Track | standard |
| Linked regimen | None |
| ID | IND-ESOPH-DEFINITIVE-CRT-SCC |
|---|---|
| Type | Indication |
| Status | reviewed 2026-05-08 | pending_clinical_signoff |
| Diseases | DIS-ESOPHAGEAL |
| Sources | SRC-ESMO-ESOPHAGEAL-2024 SRC-NCCN-ESOPHAGEAL-2025 SRC-RTOG-8501-HERSKOVIC-1992 |
Notes
§17 phased indication using new RadiationCourse schema. Single phase type=chemoradiation with radiation_id=RC-DEFINITIVE-ESOPH-SCC; the RadiationCourse owns concurrent_chemo_regimen=REG-CARBO-PACLI-CONCURRENT-RT-ESOPH per planning doc §2.3 (XOR rule on phase fields). Salvage esophagectomy for persistent / recurrent disease post-definitive-CRT is a separate indication path (not modeled here).
Used By
Algorithms
ALGO-ESOPH-DEFINITIVE-1L- ALGO-ESOPH-DEFINITIVE-1L